Most CB1 antagonists reported so far are close analogs or isosteres of rimonabant.
目前报道的大多数 CB1 拮抗剂都是利莫那班的类似物或同工物。
Furthermore, by the side of treating central nerve system disease, the antagonists of CB1 receptor show good activity too.
而且,在治疗中枢神经系统疾病方面,CB 1受体抑制剂也表现出较好的药理活性。
The researchers found that when they blocked CB1 receptors with a drug, rats lost interest in eating additional fat (but not other types of food).
研究者们发现当用药物将CB 1受体阻断后,小鼠丧失了摄取更多脂肪的兴趣(对其他食物的兴趣依然不减)。
应用推荐